The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The real-world experience of adjuvant docetaxel and cyclophosphamide (TC) chemotherapy in HER-2 negative breast cancer.
 
Danilo Giffoni M. M. Mata
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose
 
Andrea Eisen
Other Relationship - Cancer Care Ontario
 
Rossanna C. Pezo
Honoraria - Merck; Novartis Canada Pharmaceuticals Inc; Pfizer/EMD Serono
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; EMD Serono; Genomic Health; Lilly; Merck; Mylan; Myriad Genetics; Novartis Canada Pharmaceuticals Inc; Pfizer; Tersera
Speakers' Bureau - Novartis Canada Pharmaceuticals Inc
Research Funding - Merck (Inst)
 
Ines B. Menjak
No Relationships to Disclose
 
Maureen E. Trudeau
Stock and Other Ownership Interests - RNA Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Eisai (Inst); Genomic Health (Inst); Novartis (Inst); Pfizer (Inst); Roche Canada (Inst)